Dr. Ravdin et al published a very impressive article in this week's New England Journal of Medicine on hormone replacement therapy (HRT) use and breast cancer rates.
They showed that the incidence (number of new cases) of breast cancer decreased in women who were 50 years of age or older from 2002 through the end of 2004.
They tie this to the decrease in postmenopausal hormone replacement therapy and note that the decrease was largely in the number of new cases of estrogen receptor...


